Pfizer to lose crown to Sanofi as world’s biggest drug maker
Source EP Vantage
Company Sanofi
Related: Abbott Laboratories, AstraZeneca, Bayer, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck & Co, Novartis, Novo Nordisk, Pfizer, Roche, Takeda, Teva Pharmaceutical Industries
Date October 31, 2011
After nine years as the world’s biggest maker of medicines, Pfizer is set to cede its crown next year to a company that a decade ago few would have predicted to be leading the pharma league tables – Sanofi.
Sanofi is expected to retain the top spot until at least 2016 with Pfizer relegated to third place, behind Novartis, toppled by the loss of mega-blockbuster drug Lipitor, consensus sales forecasts from EvaluatePharma show. The French drug maker has raced up the rankings over the last decade largely through acquisition, culminating in its $20bn swoop on US biotechnology specialist Genzyme, which assisted in securing pole position (see table below).
Más
Click sobre imagen para ampliar
Entradas
No hay comentarios:
Publicar un comentario